Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

FP7

NeoStrep

Project ID: 601743
Financé au titre de

Development of Group B Streptococcal vaccine to alleviate emerging antibiotic resistance through elimination of current prophylactic antibiotic strategies in GBS prevention

De 2013-07-01 à 2016-06-30, projet clôturé | NeoStrep Site web

Détails concernant le projet

Coût total:

EUR 7 969 300

Contribution de l'UE:

EUR 5 999 172

Coordonné à/au(x)/en:

Sweden

Appel à propositions:

FP7-HEALTH-2013-INNOVATION-2See other projects for this call

Régime de financement:

CP-FP - Small or medium-scale focused research project

Objectif

Coordinateur

LUNDS UNIVERSITET
Sweden

Contribution de l'UE: EUR 1 050 734,50


Paradisgatan 5c
22100 LUND
Sweden
Activity type: Higher or Secondary Education Establishments
Contact administratif: Stina Ahlenius
Tél.: +46 46173465
Fax: +46 46130064
E-mail

Participants

MINERVAX APS
Denmark

Contribution de l'UE: EUR 3 124 600


VEDBENDVEJ 28
2900 HELLERUP
Denmark
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contact administratif: Per Fischer
Tél.: +45 20252038
E-mail
BIO-KINETIC EUROPE LIMITED
Ireland

Contribution de l'UE: EUR 1 624 077


GREAT VICTORIA STREET 14
BT2 7BA BELFAST
Ireland
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contact administratif: Crawford Maclean
Tél.: +44 2890818381
Fax: +44 2890238123
E-mail
CITOXLAB SCANTOX AS
Denmark

Contribution de l'UE: EUR 199 760,50


Hestehavevej 36A
4623 Lille Skensved
Denmark
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contact administratif: Andrew Makin
Tél.: +45 56 86 15 26
Fax: +45 56 92 12 02
E-mail

Thèmes

Life Sciences
Numéro d'enregistrement: 108885 / Dernière mise à jour le: 2016-03-31